Andere Sprachen Renalytix Plc Nasdaq

Aktien

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:50:36 03.07.2024			% 5 Tage	% 1. Jan.
0,25 ^USD	-1,11 %		+0,36 %	-35,59 %

28.06.	GEWINNE UND HANDEL: Thruvision-Verlust weitet sich aus, aber Polarean verringert den Verlust	AN
28.06.	Renalytix beantragt Anhörung bei der Nasdaq zur Aufrechterhaltung der Börsennotierung	MT

Pentwater Capital Management LP - Form 8.3 - Renalytix PLC	01.07.
ADRs Advance; Connect Biopharma Holdings Climbs 19%	28.06.
EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows	28.06.
Pentwater Capital Management LP - Form 8.3 - Renalytix plc	28.06.
Renalytix Requests Nasdaq Hearing to Address Listing Compliance	28.06.
Renalytix Requests Hearing With Nasdaq to Maintain Listing	28.06.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	27.06.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	26.06.
Shares in Renalytix plunge on possible ADS suspension on Nasdaq	25.06.
Renalytix to Appeal Nasdaq Delisting Over Non-compliance	25.06.
Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination	14.06.
Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test	14.06.
Shares in Renalytix jump as Medicare issues LCD for kidneyintelX.dkd	14.06.
Certain Ordinary Shares of Renalytix Plc are subject to a Lock-Up Agreement Ending on 11-JUN-2024.	11.06.
Renalytix Files Registration Statement on Behalf of Selling Shareholders	06.06.
EXECUTIVE CHANGES: Resolute Mining hires former Acacia exec as chair	29.05.
Renalytix Plc Designates Joel R. Jung as Principal Accounting Officer	28.05.
Renalytix CFO Steps Down; Interim Successor Named	28.05.
Renalytix plc Announces Chief Financial Officer Changes	28.05.
Renalytix Plans to Sell American Depositary Shares for Up to $15 Million	21.05.

Keine Ergebnisse zu dieser Suche